The University of Oklahoma today announced an historic $150 million gift from Harold Hamm, the largest single gift in university history, to lift the health of Oklahoma by advancing health education, research and discovery, strengthening the state’s health care workforce and accelerating the pursuit of breakthroughs against Oklahoma’s critical public health challenges.

The University of Oklahoma’s Fran and Earl Ziegler College of Nursing has received over $5 million in additional funding through a National Institutes of Health initiative to support four maternal health research projects over the next four years.

Do I buy groceries or pay the electric bill? Should I pawn some of my belongings to afford my prescription? My child is sick, so I will have to miss work to take care of him. Those are just a few of the difficult choices that OU-Tulsa health professional students confronted during the Community Access to Resources Experience.

Patients with ultra-high-risk multiple myeloma, an aggressive form of blood cancer, often respond poorly to standard treatments, including bone marrow transplant. A University of Oklahoma physician-researcher recently received $2.9 million in funding from the National Cancer Institute to study whether RedHill Biopharma’s drug opaganib, given after CAR T-cell therapy, can help the immune cells fight cancer more effectively.

A protein called Miro1 found at elevated levels in the skeletal muscle of people with type 2 diabetes may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published today in Nature Communications. Researchers found that removing Miro1 restored the muscles’ response to insulin in preclinical models, while exercise reduced the protein’s levels in people with type 2 diabetes.